Breast cancer in Arab populations: molecular characteristics and disease management implications.

Breast cancer is a major health problem in both developing and developed countries. It is the most frequently diagnosed female malignant disease in Arab populations. The incidence of breast cancer is lower in Arab countries than in Europe and the USA but is rising fast. Breast cancers in women from Arab populations have different characteristics to those reported in individuals from Europe and the USA. For example, affected patients are at least a decade younger, they have a more advanced stage of disease at first presentation, and their tumour size is larger. Moreover, in some Arab populations, reports suggest increased axillary-lymph-node invasion, a larger proportion of negative hormone receptors, and a higher tumour grade. These disparities are not only confined to clinicopathological features but also exist at the molecular level, as shown by findings of genome-wide association studies and expression profiling.

[1]  Ayesha Ahmed,et al.  Protein expression profile and prevalence pattern of the molecular classes of breast cancer - a Saudi population based study , 2010, BMC Cancer.

[2]  F. Geara,et al.  Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

[3]  T. Dork,et al.  BRCA1 and BRCA2 mutations in breast cancer patients from Saudi Arabia. , 2002, Saudi medical journal.

[4]  Lotfi Chouchane,et al.  Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians , 2012, Breast Cancer Research and Treatment.

[5]  S. Merajver,et al.  Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients , 2008, Breast Cancer Research and Treatment.

[6]  D. Bercovich,et al.  A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer , 2007, BMC Cancer.

[7]  Terry L. Smith,et al.  Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Bingshu E. Chen,et al.  Epidemiology of inflammatory breast cancer (IBC). , 2005, Breast disease.

[9]  Y. Bignon,et al.  Complete mutation screening and haplotype characterization of BRCA1 gene in Tunisian patients with familial breast cancer. , 2008, Cancer Biomarkers.

[10]  A. Darzi,et al.  Tackling cancer burden in the Middle East: Qatar as an example. , 2012, The Lancet Oncology.

[11]  S. Merajver,et al.  High Proportion of Inflammatory Breast Cancer in the Population‐Based Cancer Registry of Gharbiah, Egypt , 2009, The breast journal.

[12]  H. Boussen,et al.  Inflammatory breast cancer in Tunisia: reassessment of incidence and clinicopathological features. , 2008, Seminars in oncology.

[13]  A. Alshatwi,et al.  Differential Expression Profile and Genetic Variants of MicroRNAs Sequences in Breast Cancer Patients , 2012, PloS one.

[14]  L. Fritschi,et al.  Breast cancer among Yemeni women using the National Oncology Centre Registry 2004-2010. , 2012, Cancer epidemiology.

[15]  P. Levine,et al.  Increasing evidence for a human breast carcinoma virus with geographic differences , 2004, Cancer.

[16]  Richard Paterson,et al.  Consanguinity and congenital heart disease in Saudi Arabia. , 2001, American journal of medical genetics.

[17]  L. Kawar Barriers to breast cancer screening participation among Jordanian and Palestinian American women. , 2013, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[18]  S. B. Abdelkrim,et al.  Breast cancer in Tunisia: clinical and pathological findings. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[19]  Wh Sit,et al.  Cancer Genomics & Proteomics , 2007 .

[20]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[21]  M. E. El May,et al.  Descriptive analysis of molecular subtypes in Tunisian breast cancer , 2014, Asia-Pacific journal of clinical oncology.

[22]  M. Al-Kuwari,et al.  Study exploring breast cancer screening practices amongst Arabic women living in the State of Qatar , 2011 .

[23]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[24]  G. Sauter,et al.  Predominance of high-grade pathway in breast cancer development of Middle East women , 2005, Modern Pathology.

[25]  S. Al-Sobhi,et al.  Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population , 1999, Medical oncology.

[26]  S. Merajver,et al.  RhoC Induces Differential Expression of Genes Involved in Invasion and Metastasis in MCF10A Breast Cells , 2004, Breast Cancer Research and Treatment.

[27]  F. de Longueville,et al.  Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differences. , 2008, Cancer genomics & proteomics.

[28]  A. Qattan,et al.  Gene expression profiling in women with breast cancer in a Saudi population. , 2008, Saudi medical journal.

[29]  A. Zekri,et al.  MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[30]  M. Al-Moundhri,et al.  The outcome of treatment of breast cancer in a developing country--Oman. , 2004, Breast.

[31]  A. Bener,et al.  Does consanguinity lead to decreased incidence of breast cancer? , 2010, Cancer epidemiology.

[32]  G. Pals,et al.  Patterns of allelic loss at the BRCA1 locus in Arabic women with breast cancer. , 2000, International journal of molecular medicine.

[33]  A. Bener,et al.  Parental consanguinity and risk of breast cancer: a population-based case-control study. , 2005, Medical science monitor : international medical journal of experimental and clinical research.

[34]  Ayesha Ahmed,et al.  Very low prevalence of epidermal growth factor receptor (EGFR) protein expression and gene amplification in Saudi breast cancer patients , 2011, Diagnostic pathology.

[35]  A. Alshatwi,et al.  A single‐nucleotide polymorphism in the TP53 and MDM‐2 gene modifies breast cancer risk in an ethnic Arab population , 2012, Fundamental & clinical pharmacology.

[36]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[37]  Hesahm Najjar,et al.  Age at diagnosis of breast cancer in Arab nations. , 2010, International journal of surgery.

[38]  P. Levine,et al.  Inflammatory breast cancer in Tunisia , 2010, Cancer.

[39]  S. Ahmed,et al.  Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma. , 2006, Human immunology.

[40]  E. Ibrahim,et al.  Breast cancer screening: review of benefits and harms, and recommendations for developing and low-income countries , 2013, Medical Oncology.

[41]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[42]  Brigitte Rack,et al.  Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer , 2010, Breast Cancer Research.

[43]  L. Chouchane,et al.  Apolipoprotein A1 −75 G/A and +83 C/T polymorphisms: susceptibility and prognostic implications in breast cancer , 2011, Molecular Biology Reports.

[44]  Martin Krapcho,et al.  SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations) , 2012 .

[45]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[46]  R. Simon,et al.  Biological markers in breast carcinoma: III. Clinical correlations with carcinoembryonic antigen , 1977, Cancer.

[47]  E. Friedman,et al.  Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel , 2012, International journal of cancer.

[48]  A. Bener,et al.  CONSANGUINEOUS MARRIAGE IN A NEWLY DEVELOPED COUNTRY: THE QATARI POPULATION , 2004, Journal of Biosocial Science.

[49]  Halim Barakat,et al.  The Arab world , 1993 .

[50]  Miri Cohen,et al.  Health beliefs and rates of breast cancer screening among Arab women. , 2006, Journal of women's health.

[51]  A. Miller,et al.  Breast screening in the emerging world: high prevalence of breast cancer in Cairo. , 2005, Breast.

[52]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[53]  E. Chouery,et al.  Prevalance of BRCA1 and BRCA2 mutations in familial breast cancer patients in Lebanon , 2012, Hereditary cancer in clinical practice.

[54]  S. Kamal,et al.  Risk factors for breast cancer in Pakistani women aged less than 45 years , 2004, Annals of human biology.

[55]  A. Fakhro,et al.  Breast cancer: patient characteristics and survival analysis at Salmaniya medical complex, Bahrain. , 1999, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[56]  Wei Zheng,et al.  Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. , 2011, The Lancet. Oncology.

[57]  A. Alshatwi,et al.  Single nucleotide polymorphisms in the p21 and bcl2 cancer susceptibility genes and breast cancer risk in Saudi Arabia. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[58]  Christian A. Rees,et al.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[59]  C. Adebamowo,et al.  Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. , 2011, The Lancet. Oncology.

[60]  Y. Bignon,et al.  BRCA1 mutations in Algerian breast cancer patients: high frequency in young, sporadic cases , 2008, International Journal of Medical Sciences.

[61]  C. Bruker,et al.  ODAM Expression Inhibits Human Breast Cancer Tumorigenesis , 2011, Breast cancer : basic and clinical research.

[62]  T. Messai,et al.  Breast cancer in Tunisia in 2004: a comparative clinical and epidemiological study. , 2008, Bulletin du cancer.

[63]  W. Ruan,et al.  Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies , 2011, Breast Cancer Research and Treatment.

[64]  M. Seoud,et al.  Trends in epidemiology and management of breast cancer in developing Arab countries: a literature and registry analysis. , 2007, International journal of surgery.

[65]  A. Alachkar,et al.  Association of polymorphisms in one-carbon metabolizing genes with breast cancer risk in Syrian women , 2012, Tumor Biology.

[66]  M. Simon,et al.  Knowledge, Attitudes, and Beliefs of Arab-American Women Regarding Inherited Cancer Risk , 2013, Journal of Genetic Counseling.

[67]  R. Arriagada,et al.  Dermal lymphatic emboli in inflammatory and noninflammatory breast cancer: a French-Tunisian joint study in 337 patients. , 2005, Clinical breast cancer.

[68]  A. Teebi,et al.  Genetic Diversity among the Arabs , 2005, Public Health Genomics.